UDIBI

Fecha de publicación: 28 de agosto de 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies Ver más

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....

Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS

Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS

Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...

Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...

Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. VER MÁS

Phage Display Libraries for Antibody Therapeutic Discovery and Development. VER MÁS